Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|5|3|163-175

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.5, Iss.3, 2011-09, pp. : 163-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biphasic (Premix) Insulin Analogs in Type 2 Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 1, 2011-01 ,pp. : 66-73

Bentham Science Publishers

Access to resources Recommend Favorite

Hitting the Jackpot Twice: Identifying and Patenting Gene Tests Related to Muscle Lipid Accumulation for Meat Quality in Animals and Type 2 Diabetes/Obesity in Humans

By  

Recent Patents on DNA & Gene Sequences, Vol. 1, Iss. 2, 2007-06 ,pp. : 100-111

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges for the Treatment of Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 203-209

Bentham Science Publishers

Access to resources Recommend Favorite